Dr Clifford Paul Gryte, MD | |
1215 Duff Ave, Ames, IA 50010-5400 | |
(515) 239-4448 | |
(515) 239-4741 |
Full Name | Dr Clifford Paul Gryte |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1215 Duff Ave, Ames, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265421549 | NPI | - | NPPES |
1109348 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 19931 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Clifford Paul Gryte, MD 1215 Duff Ave, Ames, IA 50010-5400 Ph: (515) 239-4448 | Dr Clifford Paul Gryte, MD 1215 Duff Ave, Ames, IA 50010-5400 Ph: (515) 239-4448 |
News Archive
Female soccer players and soccer players who have had a previous concussion recuperate differently from males or players without a history of concussion, new research released today at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at the JW Marriott Orlando Grande Lakes shows.
"IDPs" is now a widely used acronym that stands for "intrinsically disordered proteins." It is the term generally used by the scientific community to refer to a wide variety of proteins that do not have a stable 3D structure and are instead characterized by a high extent of local mobility, disorder and many conformers that are accessible at room temperature.
A man has a one in six chance of being diagnosed with prostate cancer. Each year, more than 230,000 men are diagnosed with the disease. Doctors have traditionally recommended two tests for the early detection of prostate cancer; the prostate specific antigen (PSA) test and digital rectal exam (DRE) are used to detect abnormalities with the prostate gland.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers.
› Verified 2 days ago
Dr. Jon Lowell Fagre, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5601 N Swing, Ames, IA 50014 Phone: 515-291-4353 | |
Dr. Donald Warren Powers, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2538 Eisenhower, Ames, IA 50010 Phone: 515-232-0572 | |
Christopher J. Johnson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Mcfarland Clinic Pc, Ames, IA 50010 Phone: 515-239-4448 Fax: 515-239-4741 | |
Dr. Trisha Lynn Andersen, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4448 Fax: 515-239-4741 | |
Jamie A. Weydert, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Mcfarland Clinic, Pc, Ames, IA 50010 Phone: 515-239-4448 Fax: 515-239-4741 |